Comments
Loading...
Palisade Bio (PALI) Forecast
NewsEarningsPalisade Bio (PALI) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestPalisade Bio (NASDAQ:PALI) Stock Quotes, Forecast and News Summary
Palisade Bio Stock (NASDAQ: PALI) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Palisade Bio (PALI) stock?
You can purchase shares of Palisade Bio (NASDAQ:PALI) through any online brokerage.
Who are Palisade Bio (PALI) competitors?
Other companies in Palisade Bio’s space includes: Vincerx Pharma (NASDAQ:VINC), Tharimmune (NASDAQ:THAR), Entero Therapeutics (NASDAQ:ENTO), Synaptogenix (NASDAQ:SNPX) and Quoin Pharmaceuticals (NASDAQ:QNRX).
What is the forecast, or price target, for Palisade Bio (PALI) stock?
Palisade Bio has a consensus price target of $20.67.
What is the current price for Palisade Bio (PALI)?
The stock price for Palisade Bio (NASDAQ: PALI) is $0.9561 last updated February 21, 2025 at 7:54 AM EST.
Does Palisade Bio (PALI) pay a dividend?
There are no upcoming dividends for Palisade Bio.
When is Palisade Bio (NASDAQ:PALI) reporting earnings?
Palisade Bio’s Q1 earnings are confirmed for Monday, May 12, 2025.
Is Palisade Bio (PALI) going to split?
There is no upcoming split for Palisade Bio.
What sector and industry does Palisade Bio (PALI) operate in?
Palisade Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.